Pemazyre Approved for Treatment of Advanced Cholangiocarcinoma

MONDAY, April 20, 2020 -- Pemazyre (pemigatinib) has been granted accelerated approval for the treatment of advanced cholangiocarcinoma, the U.S. Food and Drug Administration announced Friday. The drug approval is indicated for previously treated...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news